Business Description
Asarina Pharma AB
ISIN : SE0011641794
Share Class Description:
ASRPF: Ordinary SharesCompare
Compare
Traded in other countries / regions
ASAP.SwedenAPS.GermanyASRPF.USA IPO Date
2019-11-27Description
Asarina Pharma AB is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion and neurological disorders. Its product pipeline is built on over 40 years of research into llopregnanolone-related neurological disorders. With the new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) the company aims to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.16 | |||||
Equity-to-Asset | 0.27 | |||||
Debt-to-Equity | 0.61 | |||||
Debt-to-EBITDA | N/A |
N/A
|
N/A
| |||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 47.4 | |||||
3-Year EPS without NRI Growth Rate | 47.9 | |||||
3-Year FCF Growth Rate | 50.5 | |||||
3-Year Book Growth Rate | -70.4 |
Momentum Rank
Name | Current | Vs Industry | Vs History |
---|
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.2 | |||||
Quick Ratio | 1.2 | |||||
Cash Ratio | 0.71 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.5 | |||||
Shareholder Yield % | 25.32 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History |
---|
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
PB Ratio | 10.27 | |||||
Price-to-Tangible-Book | 10.65 | |||||
EV-to-EBIT | -1.02 | |||||
EV-to-EBITDA | -1.05 | |||||
EV-to-FCF | -1.31 | |||||
Price-to-Net-Current-Asset-Value | 18.85 | |||||
Earnings Yield (Greenblatt) % | -98.04 | |||||
FCF Yield % | -66.38 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:ASRPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Asarina Pharma AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | 0 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 0 | ||
14-Day ATR ($) | 0 | ||
20-Day SMA ($) | 0 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range ($) | 2.45 - 2.45 | ||
Shares Outstanding (Mil) | 22.64 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Asarina Pharma AB Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Asarina Pharma AB Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Asarina Pharma AB Frequently Asked Questions
What is Asarina Pharma AB(ASRPF)'s stock price today?
The current price of ASRPF is $2.45. The 52 week high of ASRPF is $2.45 and 52 week low is $2.45.
When is next earnings date of Asarina Pharma AB(ASRPF)?
The next earnings date of Asarina Pharma AB(ASRPF) is 2024-08-23 Est..
Does Asarina Pharma AB(ASRPF) pay dividends? If so, how much?
Asarina Pharma AB(ASRPF) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |